Who’s new at OHSU? Nathalie Pamir, Ph.D.

Nathalie Pamir, Ph.D., is an assistant professor in the School of Medicine, Knight Cardiovascular Institute (KCVI), where she focuses on preventive cardiology. Where are you from originally? I’m from a Russian family but I was born in Turkey and spent my childhood there. I then went through the French school system and returned to Turkey to get my undergraduate degree. From there I moved to Vancouver, B.C., where I earned my master’s degree at the … Read More

New services for OHSU entrepreneurs

Entrepreneurs at OHSU: you now have access to technology development resources via a new agreement with Virogenomics BioDevelopment, a 2015 spin-off of OHSU and Virogenomics, Inc. Working with universities across Oregon, biotech companies, and national institutions, Virogenomics brings together the scientific, regulatory, and funding components necessary to move technology out of the lab and into the marketplace. The idea is to help investigators find solutions to common problems such as applying for and managing STTR/SBIR … Read More

Who’s new at OHSU? Sudarshan Anand

Sudarshan Anand, Ph.D., is an assistant professor in the School of Medicine’s Departments of Cell, Developmental & Cancer Biology and Radiation Medicine. He arrived at OHSU in March 2014 and is one of a team of researchers at OHSU examining factors that shape the tumor microenvironment. Where are you from originally and what shaped your early career? I was born and raised in India and came to the U.S. in 2001 for graduate school. I … Read More

Limited submission funding process refresher

Faculty and departments have recently been asking “What should I do when I’m applying for a grant and I notice that only one application is accepted per institution?” To clarify what’s involved in identifying and applying for limited submission funding opportunities, the following information should help those of you who are new to the process and anyone else who may need a refresher. What is a limited submission? Limited submission funding opportunities are programs in … Read More

OHSU researchers launch initiative to reduce transplant wait times

As many as 22 patients die each day while waiting for a needed organ. Beyond the human cost, the U.S. health care system spends billions of dollars on life-sustaining treatments for those on the organ transplant waiting list. On June 13, the White House unveiled a new initiative to address challenges associated with organ donation and transplantation in the U.S. Included in the key actions is a three-year, $4.2 million grant to researchers at OHSU, as … Read More

Finding funding, simplified

The workload associated with administrative requirements on grants is ever increasing and well documented. Identifying the appropriate funding opportunities to apply for in the first place is an additional burden you don’t need. OHSU Research Funding and Development Services is here to help! Sign up for our Weekly Funding Alerts email, which features opportunities covering the broad range of research conducted across OHSU. Interested in more targeted searches? Check out OHSU’s Funding Portal for information on internal and foundation funding … Read More

The data on the competition for NIH funding

We all know the NIH budget is not keeping pace with demand and that success rates are at historically low levels but what are the actual numbers that reflect the funding climate? NIH’s Deputy Director for Extramural Research Mike Lauer addresses this question in detail in his May 31 Open Mike blog post, “How Many Researchers?” Using published findings from a workshop held at the University of Wisconsin-Madison (Kimble et al.) as a starting point, Lauer explores the … Read More

OCTRI announces 2017 Catalyst Award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the recipients of the 2017 Catalyst Award. This grant is designed to support novel, collaborative research initiatives at OHSU. “This year’s Catalyst Award is responsive to the need for novel methodologies that can improve and accelerate translational research,” said David Ellison, M.D., professor of medicine (physiology and pharmacology), OHSU School of Medicine, and director of OCTRI. “We are delighted to support these innovative … Read More

TTBD Industry Spotlight: GE Healthcare and OHSU

OHSU continues to collaborate with industry giants, pushing the boundaries of medicine and health care forward. In 2013, OHSU partnered with Intel to create computer architectures for sequencing cancer genomes and personalizing cancer care. In 2015, OHSU joined with Apple, Inc. to create a technology that detects the warning signs of melanoma through photographs taken with an iPhone. This year, OHSU and GE Healthcare are finalizing collaborations on numerous health care projects, including cardiovascular research, … Read More

Who’s new at OHSU? Alexey Danilov, M.D., Ph.D.

Alexey Danilov, M.D., Ph.D., is an assistant professor of medicine (hematology and oncology), OHSU School of Medicine, and member of the Knight Cancer Institute. He focuses on treating and diagnosing patients with chronic lymphocytic leukemia (CLL) and various lymphomas. He has been at OHSU for a year, arriving in October 2014. Where are you from originally? I’m originally from Russia, but I did most of my training in the New England area of the U.S. … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.